The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Thymidilate synthase gene copy number as predictive marker of capecitabine efficacy in patients with breast cancer.
R. Audet
No relevant relationships to disclose
R. Duchnowska
No relevant relationships to disclose
K. Adamowicz
No relevant relationships to disclose
J. Zok
No relevant relationships to disclose
W. Rogowski
No relevant relationships to disclose
M. M. Litwiniuk
No relevant relationships to disclose
S. Debska
No relevant relationships to disclose
M. Jaworska
No relevant relationships to disclose
M. Foszczynska-Kloda
No relevant relationships to disclose
M. Kulma-Kreft
No relevant relationships to disclose
K. Zabkowska
No relevant relationships to disclose
C. Shen
No relevant relationships to disclose
S. Edgerton
No relevant relationships to disclose
K. V. Nielsen
Employment or Leadership Position - DAKO
A. D. Thor
No relevant relationships to disclose
J. C. N. Chang
No relevant relationships to disclose
K. Miller
No relevant relationships to disclose
J. Jassem
No relevant relationships to disclose
G. W. Sledge
No relevant relationships to disclose
B. Leyland-Jones
No relevant relationships to disclose